2013
DOI: 10.1007/s11695-013-0985-0
|View full text |Cite
|
Sign up to set email alerts
|

Duodenal–Jejunal Bypass Surgery Up-Regulates the Expression of the Hepatic Insulin Signaling Proteins and the Key Regulatory Enzymes of Intestinal Gluconeogenesis in Diabetic Goto–Kakizaki Rats

Abstract: DJB is effective in up-regulating the expression of the key proteins in the hepatic insulin signaling pathway and the key regulatory enzymes of intestinal gluconeogenesis and down-regulating the expression of the key regulatory enzymes of hepatic gluconeogenesis without weight loss. Our study helps to reveal the potential role of hepatic insulin signaling pathway and intestinal gluconeogenesis in ameliorating insulin resistance after metabolic surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(29 citation statements)
references
References 40 publications
3
26
0
Order By: Relevance
“…It is strongly suggested that, intestinal glucose release may take place during the postabsorptive period after gastric bypass surgery in obese humans [49,50]. It must also be noted that data from our study in mice [48] have recently been supported by a similar study of bypass surgery in the Goto-Kakisaki diabetic rat [51]. Finally, it must be emphasized that intestinal gluconeogenesis curbing hunger sensation and improving insulin sensitivity, and glucagon-like peptide 1 secretion improving insulin secretion, may act in synergy to promote the whole beneficial effect of gastric bypass surgeries on glucose and energy homeostasis [52].…”
Section: Intestinal Gluconeogenesis In Gastric Bypasssupporting
confidence: 60%
“…It is strongly suggested that, intestinal glucose release may take place during the postabsorptive period after gastric bypass surgery in obese humans [49,50]. It must also be noted that data from our study in mice [48] have recently been supported by a similar study of bypass surgery in the Goto-Kakisaki diabetic rat [51]. Finally, it must be emphasized that intestinal gluconeogenesis curbing hunger sensation and improving insulin sensitivity, and glucagon-like peptide 1 secretion improving insulin secretion, may act in synergy to promote the whole beneficial effect of gastric bypass surgeries on glucose and energy homeostasis [52].…”
Section: Intestinal Gluconeogenesis In Gastric Bypasssupporting
confidence: 60%
“…Also, acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats [18]. It is worth mentioning that 20 weeks after duodenal -jejunal bypass in Goto-Kakizaki rats, G6PC levels within the liver were lower than in the SHAM operated group [9]. DJB operation consists of elements other than IT, but the effect could be similar, meaning low levels of G6PC in the liver.…”
Section: Discussionmentioning
confidence: 94%
“…All surgical and experimental procedures were precisely described earlier by our research group [3,13], thus in this paper we briefly present only the main points. The animal experimental protocols were approved by the Ethics Committee of the University of Freiburg [3,9,13]. In short, 11 to 12-week-old, 200-220 g, obese male Zucker rats (Crl:ZUC-Lepr fa ) were purchased from Charles River Breeding Laboratories (Wilmington, Mass).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Simultaneously, PI3K-AKT activation phosphorylates Foxo1 proteins and decreases the expression of gluconeogenic genes, such as Pepck and G6pase [16]. Sun et al [34] found that duodenal-jejunal bypass could significantly downregulate the expression of the key regulatory enzymes of hepatic gluconeogenesis without weight loss in diabetic GK rats. However, Gerhard et al [35] reported that hepatic GS gene expression and glycogen content were not different between nondiabetic and diabetic patients, and no remission were observed in patients with diabetes after RYGB.…”
Section: Discussionmentioning
confidence: 99%